Cairo – Mubasher: The ordinary general meeting (OGM) of Nile Co. for Pharmaceuticals and Chemical Industries (Nile Pharma) approved a cash dividend distribution of EGP 2 per share for the earnings of fiscal year (FY) 2020/2021.
The OGM also approved an employee profit share of EGP 7.344 million for the year ended 30 June, the company said in a bourse disclosure on Wednesday.
The company reported net profits of EGP 64.42 million in FY20/21, down from EGP 93.38 million a year earlier.
